- Department of Pharmacy and Biotechnology, Alma Mater Studiorum, Bologna, Italy
Motivation: The definition of the genome distribution of the Myc transcription factor is extremely important since it may help predict its transcriptional activity particularly in the context of cancer. Myc is among the most powerful oncogenes involved in the occurrence and development of more than 80% of different types of pediatric and adult cancers. Myc regulates thousands of genes which can be in part different, depending on the type of tissues and tumours. Myc distribution along the genome has been determined experimentally through chromatin immunoprecipitation This approach, although powerful, is very time consuming and cannot be routinely applied to tumours of individual patients. Thus, it becomes of paramount importance to develop in silico tools that can effectively and rapidly predict its distribution on a given cell genome. New advanced computational tools (DeeperBind) can then be successfully employed to determine the function of Myc in a specific tumour, and may help to devise new directions and approaches to experiments first and personalized and more effective therapeutic treatments for a single patient later on.
Results: The use of DeeperBind with DeepRAM on Colab platform (Google) can effectively predict the binding sites for the MYC factor with an accuracy above 0.96 AUC, when trained with multiple cell lines. The analysis of the filters in DeeperBind trained models shows, besides the consensus sequence CACGTG classically associated to the MYC factor, also the other consensus sequences G/C box or TGGGA, respectively bound by the SP1 and MIZ-1 transcription factors, which are known to mediate the MYC repressive response. Overall, our findings suggest a stronger synergy between the machine learning tools as DeeperBind and biological experiments, which may reduce the time consuming experiments by providing a direction to guide them.
1 Introduction
The myelocytomatosis, or MYC, gene belongs to a family of oncogenes coding for transcription factors involved in cell growth and in the activation and the expression of many pro-proliferative genes. In particular the MYC gene and its coded transcription factor lie at the crossroad of many signal transduction pathways and constitutes an early response downstream of many ligand-membrane receptor complexes, (Armelin et al., 1984).Given its important role, MYC expression is heavily regulated by several molecular mechanisms acting on many trascriptional regulatory motifs found within its proximal promoter region, (LaurenceHurley et al., 2006; Lorenzin et al., 2016). MYC over expression is very common in several diagnosed types of cancer in which it is expressed constitutively, (Ahmadiyeh et al., 2010). A significant example is the Burkitt lymphoma in which MYC disregulations and mutations are well studied pathogenic causes, (Bhatia et al., 1993), (Magrath, 1990). MYC encoded protein mechanism of action involves the formation of an heterodimer with the related transcription factor MAX, (Blackwood and Eisenman, 1991) (see Figure 1 for a schematic picture of this mechanism). The heterodimer binds a 6-base DNA sequence (CACGTG) called E-box. Ifox. Iftbox1 the binding occurs within a gene promoter and possibly nearby the transcription start site of the gene, it usually results in the activation of gene transcription. MYC/Max can also bind other DNA sequences which are slightly divergent from the canonical E-box such as CAtGTG, or CACGcG and have different affinity for the transcription factor, (Eisenman, 2001). Several studies have shown that the use of different genome DNA binding sequences may depend on the internal concentration of the Myc/Max complex, (Sabo et al., 2014). In pathological condition in which the MYC gene is amplified and overexpressed, it has been found that Myc can also regulate transcription through a repressive mechanism, (Herkert and Eilers, 2010). However, in that case, it has been quite difficult to identify a specific DNA site recognized by the Myc/Max complex onto the genome. It rather seems that such repressive function is exerted by Myc by associating to chromatin through the interaction with other transcription factors. Several lines of evidence have shown that Myc can associate with either the Sp1 transcription factor or with the initiator Miz-1factor, (Iraci et al., 2011). The interaction with SP1 or MIZ-1 allows Myc to recruit or regulate multiple chromatin modifiers and readers such as Histone Deacetylases, Sirtuins, Histone Demethylases and DNA Methyl Transferase; in other words, proteins involved in inducing heterochromatin formation to silence gene transcription, (Corey et al., 2021). The possibility to predict binding of MYC to genomic DNA appears relatively easy, as it should be sufficient to bioinformatically identify the 6-base DNA sequences that can be recognized by the Myc/Max complex. However, sequence specificity alone cannot fully explain the MYC-MAX complex binding dynamic and occupancy across the genome, (Guo et al., 2014). Indeed, the binding is strictly regulated by the chromatin context. The simple methylation of the central cytosine of the E box or the methylation of any of the cytosines of the CACGCG sequence can totally abate the binding of the transcription factor to DNA, (Giovanni et al., 2005). Thus prediction of the distribution of Myc, along genome of a given cell, must take into account DNA modifications. For what regards the mapping of the Myc factor on repressed/silenced genes, the attempt is even more complicated, since at the moment we have no clue about the existence of DNA consensus sequences that can be used as marks for such an activity. The accurate prediction of the genome distribution of Myc on a given cell genome is of paramount importance, considering that Myc is one of the most powerful oncogenes directly involved in the arising and progression of more than 80% of different types of cancer. Myc regulates about two thousand genes which can be, however, in part different, depending on the type of tissues and tumours. Thus, it is a priority to devise computational tools that may help determine the function of Myc in a specific tumour, possibly in that of single patients, in order to administer personalized and more effective therapeutic treatments. Although several standard bioinformatic tools have been used to address that problem, results have not been particularly effective especially for what regards gene repressed by MYC.
Recently, the scientific community witnessed the outstanding performances of the Deep Learning algorithm in many fields, (LeCun et al., 2015), (Geoffrey, 2018), despite the fact this algorithm was originally developed for image recognition (see (Hinton et al., 1990), (Hinton et al., 2006)). The versatilily of the Deep Learning algorithm suggested then new applications in tandem with a specific encoding and representations of DNA sequences. In this work we take a further step and use the DeepBind tool, developed in the Canadian Institute for Advanced Research ((Alipanahi et al., 2015)). With a revolutionary new representation of DNA sequences, going beyond the one-hot-encoding, using data coming via the Chip-Seq databases, researchers were able to predict binding sites and further discern new patterns associated with them, (Hassanzadeh and Wang, 2016), (Trabelsi et al., 2019). There are two main advantages in using DeepBind and its refinement DeeperBind. First, DeepBind does not require a large amount of data, in comparison with the other models of DeepRAM and more generally the models coming from Deep Learning architectures. This is a very convenient feature, since large datasets are rarely available, at least not in an homogeneous fashion, in biological databases. Then, the second advantage consists in the fact that DeepBind allows the researchers to view and analyze the filters of the neural network, hence discovering the features that enabled the algorithm to detect the binding sites. For example, ChIPanalyser (see (Radu Zabet and Adryan, 2015) and refs. therein) and other similar bioconductor packages need consensus sequences and other key information about the transcription factor in order to be able to predict binding sites. On the contrary Deepbind and DeeperBind are able to find old and new consensus sequences associated to a given transcription factor, while at the same time enhancing the performance of binding site recognition. The paves the road to a revolutionary application of the Deep Learning algorithm beyond the supervised tasks. As we shall see in our present work, the analysis of the filters is able to suggest new directions in research by discovering new sequences associated with the MYC-MAX binding dynamics that could be then better explored with further experimental analysis.
2 Materials and methods
The DeepBind architecture is a convolutional neural network (CNN) with one convolutional layer followed by a non-linear thresholding, a max-pooling layer and one/two fully connected layers to estimate the intensity of inputs. The DeeperBind model, (Hassanzadeh and Wang, 2016), is a further development of DeepBind with twice the depth two LSTM (Long short-term memory) recurrent layers stacked on top of the convolutional layers. While the convolutional layers extract the features by applying several PWM-like filters, the RNN (recurrent neural network) captures the sequential dependencies of the sub-motifes identified by the convolutional part of the network.We performed the training via the DeepRAM tool on the Colab platform. It performs an automatic calibration by training 40 different models whose architecture is summarized in Figure 2, with randomly sampled hyperparameters and choosing according to the performance of the corresponding model. After the best hyperparameter set is identified, six different models are trained with it. Among this six models DeepRAM will select and save the one with the highest precision. First, we explored the model functionality and behaviour on a relatively small dataset consisting of the collection of 300 sequences from the experiments belonging to just the H1 cell line. Once done with this first exploratory run and selected the best hyperparameters, we proceeded with the training of the model with the given hyperparameters with 12,000 sequences obtained with the dataset JFK_4000 obtained by selecting 4000 sequences from the experiments in Chip-Seq. We take sequences of length 301, three times larger than the ones examined by the DeepRAM models in Deepbind and Deeperbind. We also remark that one feature of the model is the random initialization of the filters parameters: consensus sequences are learned as the algorithm progresses and determines the weights of our model.
We then sorted each of the retrieved experimental data according to the score associated to each peak, that is, the Myc binding site, selecting peaks with the highest score from each experiment. For the purpose of our study we extracted 301 nt long sequences from the hg19 human genome assembly. Each sequence was centered on the middle point of the corresponding peak. The sequences thus obtained form the set of positive sequences, in other words, the sequences bound by MYC. Given the set of positive sequences, we generated a set of negative sequences through dinucleotide shuffling, that is the process of randomly shuffling a DNA sequence while preserving the counts of the 16 different dinucleotides. In such a way, the model is prevented from simply relying on the low-level statistics of genomic regions, such as promoters or coding regions, to discriminate positives from negatives.
We summarize in the next two tables the splitting into training, validation and test that we followed for each of our datasets and the composition of our datasets in terms of positive and negative sequences:
3 Results
We run our models with different datasets elucidated in Table 1 The databases can be downloaded at https://github.com/MedChaabane/deepRAM. Column 2 in Table 1 reports the dataset label, that we use to refer to it in our paper. We summarize our results in Table 1 and Figure 3.Those results have accuracies expressed via AUC (area under the ROC curve), a statistical device, measuring the accuracy of a binary response: the closer to 1 the better is the accuracy. For a thorough explanation of this statistical concept, see (Swets, 1988) and the expository (Fawcett, 2006) with refs. Therein.
![www.frontiersin.org](https://www.frontiersin.org/files/Articles/1015993/fbinf-02-1015993-HTML/image_m/fbinf-02-1015993-g003.jpg)
FIGURE 3. Red dot represents AUC of our model, green dots the various DeepBind architectures ((Hassanzadeh and Wang, 2016) and Refs. therein).
Table 2 reports the AUC for DeepBind (ref. (Hassanzadeh and Wang, 2016)), measuring the accuracy in Myc binding site (peak) recognition for the cell line H1-hESC, in parenthesis an estimation of the error.
![www.frontiersin.org](https://www.frontiersin.org/files/Articles/1015993/fbinf-02-1015993-HTML/image_m/fbinf-02-1015993-t002.jpg)
TABLE 2. AUC of DeepBind on Myc (Hassanzadeh and Wang, 2016) on Training and Test datasets.
So, we notice an accuracy slightly larger than the original Deepbind experiments, though it is not possible to make a full comparison between experiments, due to a different training set size and context. In fact our model, a modification of Deepbind, is focussing on the myc transcription factor only and it is training on all cell lines, thus enhancing the generalization capability of our algorithm. Another important difference is that our model takes a convolution spanning 301 nt, versus the more common 100 nt one of DeepBind and DeepBinder models. We also report a more appropriate graphic comparison with the other models, with a similar training set size in Figure 3; however those models regarded also other transcription factors besides Myc.
As Figure 4 shows, at the end of the training, we can examine the learned filters, containing the information the algorithm effectively uses to reach the high accuracy binary classification.
![www.frontiersin.org](https://www.frontiersin.org/files/Articles/1015993/fbinf-02-1015993-HTML/image_m/fbinf-02-1015993-g004.jpg)
FIGURE 4. Filter 1 (above), filter 2 (below) expressing the learned consensus sequences in DeeperBind. Coloring for letters marks nucleotides, coloring for the filters indicates the values for the weights, hence their importance (the darker, the higher is the weight).
By analyzing the filters, we discovered two consensus sequences: one for the MYC factor and, surprisingly, another one, that we call “non-canonical”. Such new sequence shares similarities with the one recognized by the RPBJ factor. No other sequence emerges with the same importance as these two, as expressed in Figure 4.Interestingly, the non-canonical consensus sequence can be split into two DNA regions which share some degree of similarity with the DNA consensus sequences respectively recognized by the SP1 transcription factor (C/G rich region) or the MIZ-1 initiation factor (TGGGA), usually used by MYC to exert transcriptional repression. In order to further explore the pattern-learning capabilities of the model, we generated the position weight matrices (PWM) for the two filters in DeeperBind (see Figure 4), which better captured the consensus sequences. The position weight matrix for DNA analysis is a 4xN matrix commonly used for representation of motifs of length N in biological sequences. They are obtained from sets of aligned sequences in order to check if they are functionally related and they are now an important tool available, through various software implementations, for computational motifs search and discovery. PWM elements are calculated via the position probability matrix (PPM), which counts and normalizes the frequency of each of the four nucleotides for each position in a given sequence, and then checking the distance between their distribution in the given sequence and the distribution in a random sequence with the use of the log likelihood function (related with Kullback Leibler divergence, an effective method to measure the distance between two probability distributions). In our analysis, we first annotated all the sequences we used for our models training, assigning, when possible, a gene to each sequence. Among the 8000 sequences we started with (Table 1), we were able to identify 5591 genes. We then built two datasets containing the sequences corresponding to the genes whose expression is, respectively, promoted or repressed by Myc. In the end, comparing the annotated sequences with the validated target of Myc transcriptional activation and repression, we obtained 53 sequences (of length 301) corresponding to target transcriptional activation and 21 sequences (of length 301) corresponding to target transcriptional repression. We then tested the two PWM obtained from the models filters on each of the two datasets. We found out that the PWM obtained from the filter (through a sliding procedure) which learned the canonical consensus sequence (Figure 4, filter 2) had higher affinity (score) for 41 sequences among the 53 transcriptional activation targets compared to the non-canonical one (Figure 4, filter 1). On the other hand, the non-canonical consensus sequence (Figure 4, filter 1) had higher affinity for 14 sequences among the 21 transcriptional repression targets as expected. Our comparison is based on assigning a score to the comparison via PWM between the sequence (of length 24) of filter 1 (resp. filter 2) of Figure 4 and each sequence on each of the 21 (resp. 53) sequences of transcriptional activation (resp. repression) of Myc. In 14 (resp. 41) instances the score of filter 1 is higher than the one obtained with filter 2. We summarize our findings in Table 3.
These findings go in the direction of the current understanding of Myc binding dynamics and suggest further investigation in both confirming our qualitative findings for the new consensus sequence (Figure 4, filter 1) and then in trying new models to discover novel consensus sequences both for activation and repression. Our findings support the idea that our in silico approach can help discriminate those DNA sequences that can serve as either Myc binding site for active transcription or sites for indirect association of Myc to genes that are repressed/silenced (Table 3). The analysis, even if performed on a small annotated dataset, highlights the capabilities, not yet fully exploited, of CNN models to extract and generalize the contextual relevance of regulatory sequences. We further speculate that, with more annotated data and the consequently appropriate training, the model could learn more consensus sequences related with the functional role played by a given transcription factor.
4 Conclusion
DeeperBind paired with DeepRAM obtaines extraordinary results in predicting binding sites for the MYC factor, reaching an accuracy above 0.96 AUC, when trained with multiple cell lines (see Table 1). We notice a substantial improvement in the accuracy (AUC), when we move from a training set extracted from just one cell line to one coming from multiple (up to six) cell lines (see Figure 2): this is possibly linked to the fact that MYC factor is independent from the cell line, hence training with variations enhances the recognizing ability of the algorithm. From the analysis of the filters, we discover that the model does not only learn the consensus sequence CACGTG classically associated to the MYC factor, but learns also other motifs with less significance for the classification task. For example in Figure 2 we see the consensus sequence TGGGA, associated with the RPBJ factor, suggesting a possible correlation between the presence of MYC and RPBJ factors. We plan to explore this further in the future. In conclusion, we believe that mapping each filter on positive sequences may help to identify which filter is more relevant for the prediction and were it maps on the actual biological sequence. It also can suggest new correlations between different factors as MYC and RPBJ. These capabilities may open the path for novel biological findings without the extensive use of time and resource consuming laboratory essays.
Data availability statement
The original contributions presented in the study are included in the article/Supplementary material, further inquiries can be directed to the corresponding author.
Author contributions
All authors listed have made a substantial, direct, and intellectual contribution to the work and approved it for publication.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fbinf.2022.1015993/full#supplementary-material
References
Ahmadiyeh, Nasim, Pomerantz, Mark M., Grisanzio, Chiara, Herman, Paula, Jia, Li, Almendro, Vanessa, et al. (2010). 8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC. Proc. Natl. Acad. Sci. U. S. A. 107 (21), 9742–9746. doi:10.1073/pnas.0910668107
Alipanahi, Babak, Delong, Andrew, Weirauch, Matthew T., and Frey, Brendan J. (2015). Predicting the sequence specificities of dna- and rna-binding proteins by deep learning. Nat. Biotechnol. 33, 831–838. doi:10.1038/nbt.3300
Armelin, H. A., Armelin, M. C. S., Kelly, K., Stewart, T., Leder, P., Cochran, B. H., et al. (1984). Functional role for c-myc in mitogenic response to platelet-derived growth factor. Nature 310 (5979), 655–660. doi:10.1038/310655a0
Bhatia, K., Huppi, K., Spangler, G., Siwarski, D., Iyer, R., and Magrath, I. (1993). Point mutations in the c–myc transactivation domain are common in burkitt’s lymphoma and mouse plasmacytomas. Nat. Genet. 5 (1), 56–61. doi:10.1038/ng0993-56
Blackwood, Elizabeth M., and Eisenman, Robert N. (1991). Max: A helix-loop-helix zipper protein that forms a sequence-specific dna-binding complex with myc. Science 251 (4998), 1211–1217. doi:10.1126/science.2006410
Corey, Lourenco, Resetca, Diana, Redel, Cornelia, Lin, Peter, MacDonald, Alannah S., Ciaccio, Roberto, et al. (2021). Myc protein interactors in gene transcription and cancer. Nat. Rev. Cancer 1–13, 579–591. doi:10.1038/s41568-021-00367-9
Eisenman, Robert N. (2001). Deconstructing myc: Figure 1. Genes Dev. 15 (16), 2023–2030. doi:10.1101/gad928101
Fawcett, Tom (2006). An introduction to roc analysis. Pattern Recognit. Lett. 27, 861–874. doi:10.1016/j.patrec.2005.10.010
Geoffrey, E. (2018). Deep learning—a technology with the potential to transform health care. JAMA 320, 1101–1102. doi:10.1001/jama.2018.11100
Giovanni, Perini, Diolaiti, Daniel, Porro, Antonio, and Giuliano Della Valle, (2005). In vivo transcriptional regulation of n-myc target genes is controlled by e-box methylation. Proc. Natl. Acad. Sci. U. S. A. 102 (34), 12117–12122. doi:10.1073/pnas.0409097102
Guo, Jiannan, Li, Tiandao, Schipper, Joshua, Nilson, Kyle A., Fordjour, Francis K., Cooper, Jeffrey J., et al. (2014). Sequence specificity incompletely defines the genome-wide occupancy of myc. Genome Biol. 15 (10), 482–514. doi:10.1186/s13059-014-0482-3
Hassanzadeh, Hamid Reza, and Wang, May D. (2016). IEEE international conference on bioinformatics and biomedicine (BIBM). IEEE, 178.
Herkert, Barbara, and Eilers, Martin (2010). Transcriptional repression: The dark side of myc. Genes & cancer 1 (6), 580–586. doi:10.1177/1947601910379012
Hinton, Geoffrey E., Simon, Osindero, and Teh, Yee-Whye (2006). A fast learning algorithm for deep belief nets. Neural Comput. 18 (7), 1527–1554. doi:10.1162/neco.2006.18.7.1527
Hinton, Geoffrey E., McClelland, James L., and Rumelhart, David E. (1990). “Distributed representations,” in The philosophy of artificial intelligence.
Iraci, Nunzio, Diolaiti, Daniel, Papa, Antonella, Porro, Antonio, Valli, Emanuele, Gherardi, Samuele, et al. (2011). A SP1/MIZ1/MYCN repression complex recruits HDAC1 at the TRKA and p75NTR promoters and affects neuroblastoma malignancy by inhibiting the cell response to NGF. Cancer Res. 71 (2), 404–412. doi:10.1158/0008-5472.can-10-2627
LaurenceHurley, H. Daniel D. Von Hoff, Adam, Siddiqui-Jain, and Yang, Danzhou (2006). Drug targeting of the c-myc promoter to repress gene expression via a g-quadruplex silencer element. Seminars Oncol. 33, 498–512. doi:10.1053/j.seminoncol.2006.04.012
LeCun, Yann, Yoshua, Bengio, and Hinton, Geoffrey (2015). Deep learning. Nature 521, 436–444. doi:10.1038/nature14539
Lorenzin, Francesca, Benary, Uwe, Baluapuri, Apoorva, Walz, Susanne, Jung, Lisa A., von Eyss, Björn, et al. (2016). Author response: Different promoter affinities account for specificity in myc-dependent gene regulation. eLife.
Magrath, Ian (1990). The pathogenesis of burkitt’s lymphoma. Adv. Cancer Res. 55, 133–270. doi:10.1016/s0065-230x(08)60470-4
Radu Zabet, Nicolae, and Adryan, Boris (2015). Estimating binding properties of transcription factors from genome-wide binding profiles. Nucleic Acids Res. 43, 84–94. doi:10.1093/nar/gku1269
Sabo, Arianna, TheresiaKress, R., Pelizzola, Mattia, De Pretis, Stefano, Gorski, Marcin M., Tesi, Alessandra, et al. (2014). Selective transcriptional regulation by myc in cellular growth control and lymphomagenesis. Nature 511 (7510), 488–492. doi:10.1038/nature13537
Swets, John A. (1988). Measuring the accuracy of diagnostic systems. Science 240, 1285–1293. doi:10.1126/science.3287615
Keywords: deep learning—artificial neural network, MYC, consensus sequence, binding site, machine learning and AI
Citation: Fioresi R, Demurtas P and Perini G (2022) Deep learning for MYC binding site recognition. Front. Bioinform. 2:1015993. doi: 10.3389/fbinf.2022.1015993
Received: 10 August 2022; Accepted: 24 November 2022;
Published: 05 December 2022.
Edited by:
Wuming Gong, University of Minnesota Twin Cities, United StatesReviewed by:
Dean Felsher, Stanford University, United StatesWilliam Tansey, Vanderbilt University, United States
Copyright © 2022 Fioresi, Demurtas and Perini. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: R. Fioresi, rita.fioresi@unibo.it
†These authors have contributed equally to this work